Skip to main content
OpenTrials
Completed

NCT Number: NCT01035333

A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Albany College of Pharmacy and Health Sciences

Albany, New York, 12208, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patients preparing for gastric bypass surgery

Exclusion criteria

  • pregnancy

Treatment and study plan

Orlistat

Drug

60mg capsule three times a day for up to 6 months

Other names: Alli

Primary outcomes

  1. Weight Loss

    Time frame: 6 months

    Weight loss acheived during time on study up to 6 months.

Secondary outcomes

  1. Patient Satisfaction

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Albany College of Pharmacy and Health Sciences

Other

Collaborators

  • Albany Medical College

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Dec 18, 2009
Registry last updated
Apr 4, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.